4.5 Article

Temporal Trends and Factors Associated With Cardiac Rehabilitation Participation Among Medicare Beneficiaries With Heart Failure

Journal

JACC-HEART FAILURE
Volume 9, Issue 7, Pages 471-481

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.jchf.2021.02.006

Keywords

cardiac rehabilitation; exercise training; heart failure; health care utilizatin; Medicare; predictors

Funding

  1. Texas Health Resources Clinical Scholarship
  2. Gilead Sciences Research Scholar Program
  3. Applied Therapeutics
  4. National Institute of Aging [1R03AG067960-01]
  5. Abbott
  6. American Regent
  7. Amgen
  8. AstraZeneca
  9. Bayer
  10. Boehringer Ingelheim/Eli Lilly
  11. Boston Scientific
  12. Cytokinetics
  13. Fast BioMedical
  14. Gilead
  15. Innolife
  16. Medtronic
  17. Merck
  18. Novartis
  19. Relypsa
  20. Respicardia
  21. Roche
  22. Sanofi
  23. Vifor
  24. Windtree Therapeutics
  25. American Heart Association
  26. Intra-Cellular Therapies
  27. National Heart, Lung, and Blood Institute
  28. Patient-Centered Outcomes Research Institute

Ask authors/readers for more resources

This study aimed to assess the trends and factors associated with cardiac rehabilitation (CR) enrollment and participation among Medicare beneficiaries after the 2014 Medicare coverage expansion. The participation rates of CR among eligible patients with HF were low, with minimal increase since 2014. Factors such as younger age, male sex, nonblack race, previous cardiovascular procedures, and hospitalization at hospitals with CR facilities were associated with CR participation.
OBJECTIVES The purpose of this study was to assess temporal trends and factors associated with cardiac rehabilitation (CR) enrollment and participation among Medicare beneficiaries after the 2014 Medicare coverage expansion. BACKGROUND CR improves exercise capacity, quality of life, and clinical outcomes in heart failure (HF) with reduced ejection fraction (HFrEF). In 2014, Medicare coverage for CR was expanded to include chronic HFrEF. METHODS Among Medicare beneficiaries from quarter (Q) 1 2014 to Q2 2016, 11,696 patients from 14,258 hospitalizations with primary discharge diagnosis of HF were identified. Patients with HF with preserved ejection fraction were excluded. Quarterly CR participation rates among hospitalized HF patients within 6 months of discharge were identified through outpatient administrative claims. The predictors of CR participation were assessed with the use of a multivariable logistic regression model that included patient- and hospital-level characteristics. A secondary analysis to assess participation rates of CR after outpatient encounters for HF was performed. RESULTS Overall, only 611 (4.3%) and 349 (2.2%) eligible patients participated CR after primary hospitalization or outpatient visit for HF, respectively. There was a modest, statistically significant increase in CR participation after HF admissions (2.8% in Q1 2014; 5.0% in Q2 2016; p < 0.001) without significant increase after outpatient visits for HF (2.6% to 3.8%; p = 0.21). Younger age, male sex, nonblack race, previous cardiovascular procedures, and hospitalization at hospitals with available CR facilities were all independently associated with CR participation. CONCLUSIONS CR participation among eligible Medicare beneficiaries with HFrEF was low with minimal increase since 2014 Medicare coverage decision. Sex, race, and institution-dependent variables were independent predictors of CR participation. (C) 2021 by the American College of Cardiology Foundation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available